Comparative study of anti-inflammatory activity and acute toxicity of thick Myrtus communis L. leaf extracts cultivated in vivo and in vitro

Authors

DOI:

https://doi.org/10.14739/2409-2932.2025.3.340983

Keywords:

inflammation, common myrtle, serotonin-induced edema model, anti-exudative activity

Abstract

Inflammation is a fundamental protective biological mechanism; however, its chronic progression can lead to severe pathologies. Conventional anti-inflammatory drugs, such as corticosteroids and non-steroidal anti-inflammatory drugs, are often associated with considerable adverse effects. This necessitates the urgent search for novel, safer therapeutic agents, particularly among medicinal plants. Myrtus communis L. is well-recognized for its therapeutic properties, and its leaves have been traditionally utilized in folk medicine for the management of various inflammatory conditions.

The aim of the work was to comparatively evaluate the anti-inflammatory activity and acute toxicity of thick extracts obtained from the leaves of Myrtus communis L., cultivated in natural conditions (in vivo) and those obtained by microclonal propagation (in vitro), given the growing demand for effective and safe natural anti-inflammatory agents.

Materials and methods. Thick extracts of Myrtus communis leaves were obtained using fractional maceration with 70 % ethanol, followed by concentration via a rotary evaporator. Anti-inflammatory activity was assessed on the serotonin-induced edema model in white rats, by measuring the increase in paw volume. Experimental groups received the extracts (100 mg/kg) or ibuprofen (25 mg/kg). Additionally, the influence of the extracts on biochemical markers of inflammation (C-reactive protein, TBARS) and the blood protein profile was studied. Acute toxicity assessment was conducted in accordance with OECD guidelines, starting with a dose of 2000 mg/kg.

Results. The myrtle leaf extracts demonstrated potent anti-exudative activity, reducing paw edema by 33.55 % (in vivo extract) and 35.69 % (in vitro extract), results that are comparable to the effect observed with ibuprofen (42.11 %). The mechanism of action is likely linked to antagonism against serotonin receptors. Furthermore, the extracts significantly reduced the levels of inflammation and oxidative stress markers, concurrently contributing to the restoration of the serum protein profile. The extract obtained through microclonal propagation (in vitro) exhibited slightly superior efficacy, suggesting a potential advantage for this biotechnological approach. Acute toxicity assessment confirmed that both extracts belong to Category 5 of the toxicity classification (LD50 ≥5000 mg/kg for the in vivo thick extract and LD50 2000–5000 mg/kg for the in vitro thick extract), confirming their low acute toxicity.

Conclusions. Concentrated Myrtus communis leaf extracts derived from plants grown under natural conditions and via microclonal propagation demonstrate marked anti-inflammatory and anti-exudative activity. Biotechnological cultivation approaches may offer a promising means of obtaining raw materials with enhanced biological efficacy.

Author Biographies

O. Ye. Matsehorova, Zaporizhzhia State Medical and Pharmaceutical University

Postgraduate student of the Department of Pharmacognosy, Pharmacology and Botany

V. M. Odyntsova, Zaporizhzhia State Medical and Pharmaceutical University

PhD, DSc, Professor of the Department of Pharmacognosy, Pharmacology and Botany

Ye. O. Mykhailiuk, Zaporizhzhia State Medical and Pharmaceutical University

PhD, Associate Professor of the Department of Clinical Pharmacy, Pharmacotherapy, Pharmacognosy and Pharmaceutical Chemistry

References

Sarkar D, Bhattacharyya S. The phospholipase A2 superfamily and its role in chronic inflammatory conditions with relation to adjuster cells. In: Phospholipases in Physiology and Pathology. Elsevier; 2023. p. 111-26. https://doi.org/10.1016/B978-0-323-95698-7.00021-8

Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MN. The crucial roles of inflammatory mediators in inflammation: A review. Vet World. 2018;11(5):627-35. doi: https://doi.org/10.14202/vetworld.2018.627-635

Cocea AC, Stoica CI. Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-α in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management-A Narrative Review. J Pers Med. 2024;14(5):537. doi: https://doi.org/10.3390/jpm14050537

Bakhouche I, Aliat T, Boubellouta T, Gali L, Şen A, Bellik Y. Phenolic contents and in vitro antioxidant, anti-tyrosinase, and anti-inflammatory effects of leaves and roots extracts of the halophyte Limonium delicatulum. S Afr J Bot. 2021;139:42-9. doi: https://doi.org/10.1016/j.sajb.2021.01.030

Al-Snafi AE, Teibo JO, Shaheen HM, Akinfe OA, Teibo TK, Emieseimokumo N, et al. The therapeutic value of Myrtus communis L.: an updated review. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(7):4579-600. doi: https://doi.org/10.1007/s00210-024-02958-3

Cruciani S, Santaniello S, Garroni G, Fadda A, Balzano F, Bellu E, et al. Myrtus Polyphenols, from Antioxidants to Anti-Inflammatory Molecules: Exploring a Network Involving Cytochromes P450 and Vitamin D. Molecules. 2019;24(8):1515. doi: https://doi.org/10.3390/molecules24081515

Almeida AF, Borge GI, Piskula M, Tudose A, Tudoreanu L, Valentová K, et al. Bioavailability of Quercetin in Humans with a Focus on Interindividual Variation. Compr Rev Food Sci Food Saf. 2018;17(3):714-31. doi: https://doi.org/10.1111/1541-4337.12342

Khosropour P, Sajjadi SE, Talebi A, Minaiyan M. Anti-inflammatory effect of Myrtus communis hydroalcoholic extract and essential oil on acetic acid-induced colitis in rats. J Rep Pharm Sci. 2019;8(2):204-10. doi: https://doi.org/10.4103/jrptps.JRPTPS_8_19

Rossi A, Di Paola R, Mazzon E, Genovese T, Caminiti R, Bramanti P, et al. Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. J Pharmacol Exp Ther. 2009;329(1):76-86. doi: https://doi.org/10.1124/jpet.108.143214

Mansour RB, Beji RS, Wasli H, Zekri S, Ksouri R, Megdiche-Ksouri W, et al. Gastroprotective Effect of Microencapsulated Myrtus communis Essential Oil against Ethanol/HCl-Induced Acute Gastric Lesions. Molecules. 2022;27(5):1566. doi: https://doi.org/10.3390/molecules27051566

Samareh Fekri M, Mandegary A, Sharififar F, Poursalehi HR, Nematollahi MH, Izadi A, et al. Protective effect of standardized extract of Myrtus communis L. (myrtle) on experimentally bleomycin-induced pulmonary fibrosis: biochemical and histopathological study. Drug Chem Toxicol. 2018;41(4):408-414. doi: https://doi.org/10.1080/01480545.2018.1459670

Roll R, Höfer-Bosse Th, Kayser D. New perspectives in acute toxicity testing of chemicals. Toxicology Letters. 1986;31(Suppl.):86.

OECD. Test no. 423: Acute oral toxicity - acute toxic class method. OECD; 2002. Available from: https://doi.org/10.1787/9789264071001-en

Lipnick RL, Cotruvo JA, Hill RN, Bruce RD, Stitzel KA, Walker AP, et al. Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures. Food Chem Toxicol. 1995;33(3):223-31. doi: https://doi.org/10.1016/0278-6915(94)00136-c

Diener W, Schlede E. Acute Toxicity Class Methods: Alternatives to LD/LC50 tests. ALTEX. 1999;16:129-34.

Roll R, Riebschläger M, Mischke U, Kayser D. Neue Wege zur Bestimmung der akuten Toxizität von Chemikalien [New ways to determine the acute toxicity of chemicals]. Bundesgesundheitsblatt. 1989;32:336-341.

Mansouri MT, Hemmati AA, Naghizadeh B, Mard SA, Rezaie A, Ghorbanzadeh B. A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian J Pharmacol. 2015;47(3):292-8. doi: https://doi.org/10.4103/0253-7613.157127

Singla E, Puri G, Dharwal V, Naura AS. Gallic acid ameliorates COPD-associated exacerbation in mice. Mol Cell Biochem. 2021;476(1):293-302. doi: https://doi.org/10.1007/s11010-020-03905-5

Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857-62. doi: https://doi.org/10.1016/j.ijbiomac.2021.06.140

Ertas B, Dorucu D, Gulerturk O, Sen A, Cevik O, Cetinel S, et al. The effect of Myrtus communis L. extract on nephrolithiasis model in rats. North Clin Istanb. 2024;11(2):91-8. doi: https://doi.org/10.14744/nci.2023.09068

Li Y, Kong D, Fu Y, Sussman MR, Wu H. The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Plant Physiol Biochem. 2020;148:80-9. doi: https://doi.org/10.1016/j.plaphy.2020.01.006

Nassar MI, Aboutabl el-SA, Ahmed RF, El-Khrisy ED, Ibrahim KM, Sleem AA. Secondary metabolites and bioactivities of Myrtus communis. Pharmacognosy Res. 2010;2(6):325-9. doi: https://doi.org/10.4103/0974-8490.75449

Mechchate H, de Castro Alves CE, Es-Safi I, Amaghnouje A, Jawhari FZ, Costa de Oliveira R, et al. Antileukemic, Antioxidant, Anti-Inflammatory and Healing Activities Induced by a Polyphenol-Enriched Fraction Extracted from Leaves of Myrtus communis L. Nutrients. 2022;14(23):5055. doi: https://doi.org/10.3390/nu14235055

Downloads

Additional Files

Published

2025-11-24

How to Cite

1.
Matsehorova OY, Odyntsova VM, Mykhailiuk YO. Comparative study of anti-inflammatory activity and acute toxicity of thick Myrtus communis L. leaf extracts cultivated in vivo and in vitro. Current issues in pharmacy and medicine: science and practice [Internet]. 2025Nov.24 [cited 2026Jan.20];18(3):271-7. Available from: https://pharmed.zsmu.edu.ua/article/view/340983